Antiproliferative activity and apoptosis-inducing mechanism of L-securinine on human breast cancer MCF-7 cells

Pharmazie

Volumn 69, Issue 3, 2014, Pages 217-223

  Li, Maidong ^a   Han, Shuwen ^a   Zhang, Gang ^a   Wang, Ying ^b   Ji, Zhaoning ^a  

^a WANNAN MEDICAL COLLEGE   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LEVO SECURININE; MAMMALIAN TARGET OF RAPAMYCIN; P70S6K PROTEIN; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SECURININE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL COUNTING; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AZEPINES; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HETEROCYCLIC COMPOUNDS, BRIDGED-RING; HUMANS; LACTONES; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84897128359     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.3802     Document Type: Article

References (30)

1. Anon. (1983) [Treatment of chronic aplastic anemia with securinine-analysis of 123 cases]. Zhonghua Nei Ke Za Zhi 22: 764-766.
2. Adams JM (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev 17: 2481-2495.
3. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326. (Pubitemid 28406819)
4. Budanov AV, Karin M (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451-460.
5. Chen CR, Xia YH, Yao SY, Zhang Q, Wang Y, Ji ZN (2012) Virosecurinine induces apoptosis by affecting Bcl-2 and Bax expression in human colon cancer SW480 cells. Pharmazie 67: 351-354.
6. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116: 205-219. (Pubitemid 38167313)
7. Demain AL, Vaishnav P (2011) Natural products for cancer chemotherapy. Microb Biotechnol 4: 687-699.
8. Feng Z, Hu W, De Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67: 3043-3053. (Pubitemid 46724841)
9. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378: 1461-1484.
10. Fulda S (2010) Modulation of apoptosis by natural products for cancer therapy. Planta Med 76: 1075-1079.
11. Galsky MD, Vogelzang NJ (2010) Docetaxel-based combination therapy for castration-resistant prostate cancer. Ann Oncol 21: 2135-2144.
12. Gelinas C, White E (2005) BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev 19: 1263-1268. (Pubitemid 41003016)
13. Heinrich M, Bremner P (2006) Ethnobotany and ethnopharmacy-their role for anti-cancer drug development. Curr Drug Targets 7: 239-245. (Pubitemid 43744844)
14. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153-164. (Pubitemid 34161136)
15. Kerr JF (1965) A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol 90: 419-435.
16. Massaoka MH, Matsuo AL, Figueiredo CR, Farias CF, Girola N, Arruda DC, Scutti JA, Romoff P, Favero OA, Ferreira MJ, Lago JH, Travassos LR (2012) Jacaranone induces apoptosis in melanoma cells via ROS-mediated downregulation of Akt and p38 MAPK activation and displays antitumor activity in vivo. PLoS One 7: e38698.
17. Miyashita T, Krejewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805. (Pubitemid 24163411)
18. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
19. Newmann DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477.
20. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681. (Pubitemid 40825512)
21. Patel B, Das S, Prakash R, Yasir M (2011) Natural bioactive compound with anticancer potential. Int J Adv Pharm Sci http://www.arjournals.org/index.php/ ijaps/article/view/147
22. Reed JC, Miyashita T, Takayama S,Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S, Hanada M (1996) BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60: 23-32. (Pubitemid 26047917)
23. Strobel T, Swanson L, Korsmeyer S, Cannistra SA (1996) BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci U S A 93: 14094-14099. (Pubitemid 26424251)
24. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (2003) Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516-523. (Pubitemid 36975769)
25. Van der Hage JA, Van den Broek LJ, Legrand C, Clahsen PC, Bosch CJ, Robanus-Maandag EC, Van de Velde CJ, Van de Vijver MJ (2004) Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. Br J Cancer 90: 1543-1550. (Pubitemid 38648236)
26. Vogler M, Dinsdale D, Dyer MJ, Cohen GM (2009) Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 16: 360-367.
27. Wei J, Stebbins JL, Kitada S, Dash R, Placzek W, Rega MF, Wu B, Cellitti J, Zhai D, Yang L, Dahl R, Fisher PB, Reed JC, Pellecchia M (2010) BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. J Med Chem 53: 4166-4176.
28. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484. (Pubitemid 43199434)
29. Xia YH, Cheng CR, Yao SY, Zhang Q, Wang Y, Ji ZN (2011) L-securinine induced the human colon cancer SW480 cell autophagy and its molecular mechanism. Fitoterapia 82: 1258-1264.
30. Yang S, Zhao Q, Xiang H, Liu M, Zhang Q, XueW, Song B (2013) Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toona sinensis on human cancer cells. Cancer Cell Int 13: 12.